Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Waddill William D.
Over the trailing 90 days, Waddill William D. (Director at Protagonist Therapeutics, Inc) traded $3.3M of stock (net selling $2.5M) across 2 companies, per 12 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 12 transactions · CIK 1553338
- Net activity
- −$2.5M ($390K bought · $2.9M sold)
By Company (Trailing 90 Days)
Transactions (12)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-23 | PTGX | Buy | 9.0K | $149K | Exercise or conversion of derivative security |
| 2026-06-23 | PTGX | Sell | 9.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-23 | PTGX | Sell | 9.0K | $1.1M | Open market or private sale |
| 2026-06-11 | ANNX | Buy | 65.0K | $0 | Grant, award or other acquisition |
| 2026-06-10 | PTGX | Sell | 9.0K | $969K | Open market or private sale |
| 2026-06-10 | PTGX | Sell | 3.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-10 | PTGX | Sell | 6.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-10 | PTGX | Buy | 3.0K | $35K | Exercise or conversion of derivative security |
| 2026-06-10 | PTGX | Buy | 6.0K | $99K | Exercise or conversion of derivative security |
| 2026-05-29 | PTGX | Sell | 9.0K | $897K | Open market or private sale |
| 2026-05-29 | PTGX | Buy | 9.0K | $106K | Exercise or conversion of derivative security |
| 2026-05-29 | PTGX | Sell | 9.0K | $0 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Waddill's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.